Propofol sedation administered by cardiologists without assisted ventilation for long cardiac interventions: An assessment of 1000 consecutive patients undergoing atrial fibrillation ablation

Europace

Volumn 14, Issue 3, 2012, Pages 325-330

  Salukhe, Tushar Vilas ^a,b   Willems, Stephan ^a   Drewitz, Imke ^a   Steven, Daniel ^a   Hoffmann, Boris A ^a   Heitmann, Katrin ^a   Rostock, Thomas ^a,c  

^a UNIVERSITY HEART CENTER HAMBURG   (Germany)

^b ROYAL BROMPTON HOSPITAL   (United Kingdom)

^c JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Atrial fibrillaiton ablation; Propofol sedation; Safety

Indexed keywords

ANTIBIOTIC AGENT; MIDAZOLAM; PROPOFOL;

ADULT; ARTICLE; ASSISTED VENTILATION; CARDIOLOGIST; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; HEART ATRIUM FIBRILLATION; HEART TAMPONADE; HUMAN; HYPERSALIVATION; HYPOTENSION; LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OXYGEN SATURATION; PERICARDIOCENTESIS; PNEUMONIA; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; SEDATION; SYSTOLIC BLOOD PRESSURE;

AGED; ANESTHETICS, INTRAVENOUS; ATRIAL FIBRILLATION; CARDIAC TAMPONADE; CATHETER ABLATION; COHORT STUDIES; DEEP SEDATION; FEMALE; HUMANS; HYPOTENSION; MALE; MIDAZOLAM; MIDDLE AGED; PERICARDIOCENTESIS; PROPOFOL; RESPIRATORY INSUFFICIENCY; SIALORRHEA; TREATMENT OUTCOME;

EID: 84857849119     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eur328     Document Type: Article

References (26)

1. Haíssaguerre M, Jaís P, Shah DC, Takahashi A, Hocini M, Quiniou G et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med 1998;339:659-66. (Pubitemid 28402090)
2. Hsu LF, Jaís P, Sanders P, Garrigue S, Hocini M, Sacher F et al. Catheter ablation for atrial fibrillation in congestive heart failure. N Engl J Med 2004;351:2373-83.
3. Khan MN, Jaís P, Cummings J, Di Biase L, Sanders P, Martin DO et al., PABA-CHF Investigators. Pulmonary-vein isolation for atrial fibrillation in patients with heart failure. N Engl J Med 2008;359:1778-85.
4. Oral H, Chugh A, Yoshida K, Sarrazin JF, Kuhne M, Crawford T et al. A randomized assessment of the incremental role of ablation of complex fractionated atrial electrograms after antral pulmonary vein isolation for long-lasting persistent atrial fibrillation. J Am Coll Cardiol 2009;53:782-9.
5. Matsuo S, Lellouche N, Wright M, Bevilacqua M, Knecht S, Nault I et al. Clinical predictors of termination and clinical outcome of catheter ablation for persistent atrial fibrillation. J Am Coll Cardiol 2009;54:788-95.
6. Jaís P, Cauchemez B, Macle L, Daoud E, Khairy P, Subbiah R et al. Catheter ablation versus antiarrhythmic drugs for atrial fibrillation: The A4 study. Circulation 2008;118:2498-505.
7. Oral H, Chugh A, Good E, Sankaran S, Reich SS, Igic P et al. A tailored approach to catheter ablation of paroxysmal atrial fibrillation. Circulation 2006;113: 1824-31. (Pubitemid 43739393)
8. Oral H, Chugh A, Good E, Wimmer A, Dey S, Gadeela N et al. Radiofrequency catheter ablation of chronic atrial fibrillation guided by complex electrograms. Circulation 2007;115:2606-12. (Pubitemid 46791358)
9. Di Biase L, Saenz LC, Burkhardt DJ, Vacca M, Elayi CS, Barrett CD et al. Esophageal capsule endoscopy after radiofrequency catheter ablation for atrial fibrillation: Documented higher risk of luminal esophageal damage with general anesthesia as compared with conscious sedation. Circ Arrhythm Electrophysiol 2009;2:108-12.
10. Ronan KP, Gallagher TJ, George B, Hamby B. Comparison of propofol and midazolam for sedation in intensive care unit patients. Crit Care Med 1995;23:286-93.
11. Barrientos-Vega R, Sánchez-Soria MM, Morales-Garcia C, Cuena-Boy R, Castellano-Hernández M. Pharmacoeconomic assessment of propofol 2% used for prolonged sedation. Crit Care Med 2001;29:317-22. (Pubitemid 32171776)
12. Barrientos-Vega R, Mar Sánchez-Soria M, Morales-García C, Robas-Gómez A, Cuena-Boy R, Ayensa-Rincon A. Prolonged sedation of critically ill patients with midazolam or propofol: Impact on weaning and costs. Crit Care Med 1997; 25:33-40.
13. Cox CE, Reed SD, Govert JA, Rodgers JE, Campbell-Bright S, Kress JP et al. Economic evaluation of propofol and lorazepam for critically ill patients undergoing mechanical ventilation. Crit Care Med 2008;36:706-14.
14. Kress JP, O'Connor MF, Pohlman AS, Olson D, Lavoie A, Toledano A et al. Sedation of critically ill patients during mechanical ventilation. A comparison of propofol and midazolam. Am J Respir Crit Care Med 1996;153:1012-8.
15. Vargo JJ, Cohen LB, Rex DK, Kwo PY, American Association for the Study of Liver Diseases, American College of Gasteroenterology, American Gastroenterological Association; American Society for Gastrointestinal Endoscopy. Position statement: Nonanesthesiologist administration of propofol for GI endoscopy. Gastroenterology 2009;137:2161-7.
16. Silvestri GA, Vincent BD, Wahidi MM, Robinette E, Hansbrough JR, Downie GH. A phase 3, randomized, double-blind study to assess the efficacy and safety of fospropofol disodium injection for moderate sedation in patients undergoing flexible bronchoscopy. Chest 2009;135:41-7.
17. Lee JS, Gonzalez ML, Chuang SK, Perrott DH. Comparison of methohexital and propofol use in ambulatory procedures in oral and maxillofacial surgery. J Oral Maxillofac Surg 2008;66:1996-2003.
18. Rostock T, Steven D, Hoffmann B, Servatius H, Drewitz I, Sydow K et al. Chronic atrial fibrillation is a biatrial arrhythmia: Data from catheter ablation of chronic atrial fibrillation aiming arrhythmia termination using a sequential ablation approach. Circ Arrhythm Electrophysiol 2008;1:344-53.
19. Takahashi Y, O'Neill MD, Hocini M, Reant P, Jonsson A, Jaís P et al. Effects of stepwise ablation of chronic atrial fibrillation on atrial electrical and mechanical properties. J Am Coll Cardiol 2007;49:1306-14. (Pubitemid 46467224)
20. Gambús PL, Schnider TW, Minto CF, Youngs EJ, Billard V, Brose WG et al. Pharmacokinetics of intravenous dynorphin A(1-13) in opioid-naive and opioidtreated human volunteers. Clin Pharmacol Ther 1998;64:27-38. (Pubitemid 28377327)
21. Deegan RJ. Propofol: A review of the pharmacology and applications of an intravenous anesthetic agent. Am J Med Sci 1992;304:45-9.
22. Servin F, Cockshott ID, Farinotti R, Haberer JP, Winckler C, Desmonts JM. Pharmacokinetics of propofol infusions in patients with cirrhosis. Br J Anaesth 1990;65: 177-83. (Pubitemid 20244564)
23. Ickx B, Cockshott ID, Barvais L, Byttebier G, De Pauw L, Vandesteene A et al. Propofol infusion for induction and maintenance of anaesthesia in patients with end-stage renal disease. Br J Anaesth 1998;81:854-60. (Pubitemid 28561315)
24. Chan VW, Chung FF. Propofol infusion for induction and maintainance in the elderly: Recovery and haemodynamic profiles. J Clin Anaesth 1997;44:385-9.
25. Marinella MA. Propofol sedation in the intensive care unit: Essentials fort he clinician. Respir Med 1997;91:505-10. (Pubitemid 27397290)
26. Absalom AR, Mani V, De Smet T, Struys MM. Pharmacokinetic models for propofol-defining and illuminating the devil in the detail. Br J Anaesth 2009; 103:26-37.